NASDAQ:HSCS Heart Test Laboratories (HSCS) Stock Price, News & Analysis → Missed Nvidia? Don't Worry… (From Behind the Markets) (Ad) Free HSCS Stock Alerts $5.83 +0.09 (+1.57%) (As of 03:12 PM ET) Add Compare Share Share Today's Range$5.52▼$5.9050-Day Range$5.15▼$11.6952-Week Range$5.10▼$109.99Volume33,330 shsAverage Volume41,200 shsMarket Capitalization$3.85 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get Heart Test Laboratories alerts: Email Address Ad Porter & CompanyObama’s Forever Term [exposed]America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here About Heart Test Laboratories Stock (NASDAQ:HSCS)Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.Read More HSCS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HSCS Stock News HeadlinesJune 4 at 4:15 PM | globenewswire.comHeartSciences Regains Compliance with Nasdaq Listing RequirementsMay 20, 2024 | globenewswire.comHeartSciences Announces Further Internationalization of its AI-ECG Patent PortfolioMay 17, 2024 | msn.comHeart Test conducts 1-for-100 reverse stock splitApril 30, 2024 | msn.comResearchers develop genetic test for early detection of high cardiovascular riskApril 29, 2024 | abcnews.go.comFDA brings lab tests under federal oversight in bid to improve accuracy and safetyApril 24, 2024 | globenewswire.comHeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECGApril 13, 2024 | msn.comRoche Diagnostics India launches heart failure test for diabetics in IndiaApril 4, 2024 | msn.comEarly coronary disease, impaired heart function found in asymptomatic people with HIVApril 4, 2024 | msn.comThe Importance of Regular Lipid Profile Testing For Cardiovascular WellnessApril 2, 2024 | globenewswire.comHeartSciences to Present at the LD Micro Invitational XIV ConferenceMarch 26, 2024 | globenewswire.comHeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative PatientsMarch 15, 2024 | finanznachrichten.deHeart Test Laboratories, Inc.: HeartSciences Reports Third Quarter Fiscal 2024 Financial ResultsMarch 14, 2024 | benzinga.comRecap: Heart Test Laboratories Q3 EarningsMarch 14, 2024 | finance.yahoo.comHeartSciences Reports Third Quarter Fiscal 2024 Financial ResultsMarch 14, 2024 | globenewswire.comHeartSciences Reports Third Quarter Fiscal 2024 Financial ResultsMarch 12, 2024 | morningstar.comHeart Test Laboratories IncMarch 12, 2024 | finance.yahoo.comHeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 DiabetesMarch 12, 2024 | globenewswire.comHeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 DiabetesMarch 6, 2024 | investorplace.comWhy Is Heart Test Laboratories (HSCS) Stock Down 21% Today?March 6, 2024 | globenewswire.comHeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet TechnologyFebruary 26, 2024 | globenewswire.comHeartSciences Adds Key Advisor to its Scientific Advisory BoardFebruary 24, 2024 | forbes.comBest At-Home Blood Tests: A 2024 GuideFebruary 12, 2024 | finance.yahoo.comHeartSciences Expands its Scientific Advisory BoardFebruary 2, 2024 | msn.com'Heart-on-a-chip' to test chemotherapies and other cancer drugs for heart toxicityFebruary 1, 2024 | msn.comPromising heart drugs identified by cutting-edge combo of machine learning, human learningSee More Headlines Receive HSCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2024Today6/07/2024Next Earnings (Estimated)7/16/2024Fiscal Year End4/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:HSCS CUSIPN/A CIK1468492 Webheartsciences.com Phone682-237-7781FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($48.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,350,000.00 Net MarginsN/A Pretax Margin-33,636.84% Return on Equity-381.92% Return on Assets-134.17% Debt Debt-to-Equity RatioN/A Current Ratio5.09 Quick Ratio4.70 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.37 per share Price / Book2.46Miscellaneous Outstanding Shares660,000Free Float638,000Market Cap$3.85 million OptionableNot Optionable Beta3.14 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Andrew Simpson (Age 54)CEO, President & Chairman of the Board of Directors Comp: $264.14kMs. Danielle Watson (Age 41)CFO & Treasurer Comp: $188.75kMr. Mark T. Hilz (Age 65)COO, Secretary & Director Comp: $263.61kKey CompetitorsPredictive OncologyNASDAQ:POAINanoVibronixNASDAQ:NAOVBone BiologicsNASDAQ:BBLGLogicMarkNASDAQ:LGMKSientraNASDAQ:SIENQView All Competitors HSCS Stock Analysis - Frequently Asked Questions How have HSCS shares performed in 2024? Heart Test Laboratories' stock was trading at $17.10 at the beginning of 2024. Since then, HSCS stock has decreased by 65.8% and is now trading at $5.84. View the best growth stocks for 2024 here. Are investors shorting Heart Test Laboratories? Heart Test Laboratories saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 3,100 shares, a decline of 99.5% from the April 30th total of 617,600 shares. Based on an average trading volume of 40,900 shares, the short-interest ratio is presently 0.1 days. Currently, 0.6% of the shares of the stock are short sold. View Heart Test Laboratories' Short Interest. When is Heart Test Laboratories' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 16th 2024. View our HSCS earnings forecast. How were Heart Test Laboratories' earnings last quarter? Heart Test Laboratories, Inc. (NASDAQ:HSCS) released its earnings results on Thursday, March, 14th. The company reported ($3.00) earnings per share (EPS) for the quarter. The firm had revenue of $0.02 million for the quarter. When did Heart Test Laboratories' stock split? Heart Test Laboratories's stock reverse split on the morning of Friday, May 17th 2024. The 1-100 reverse split was announced on Friday, May 17th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. When did Heart Test Laboratories IPO? Heart Test Laboratories (HSCS) raised $9 million in an IPO on Wednesday, June 15th 2022. The company issued 1,800,000 shares at $4.50-$5.50 per share. The Benchmark Company acted as the underwriter for the IPO. How do I buy shares of Heart Test Laboratories? Shares of HSCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HSCS) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s...Weiss Ratings | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredWhat Nvidia insiders don’t want you to knowIf you missed out on Nvidia, don't worry. A 244-year-old pattern is about to trigger a $25.6 trillion AI surge...Behind the Markets | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heart Test Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.